Get started

Technologystocks

Salesforce.com: Another Software Name, Another Bullish TriangleSoftware has been one of the strongest industry groups lately as investors view it as largely immune to Covid-19. On Tuesday we highlighted Microsoft’s bullish triangle , and today another major player has a similar pattern. Salesforce.com is pushing against the $165 area that held it in check last year (flagged in this idea ). CRM has also made a series of higher lows since getting slammed lower back on April 21. The 50-day simple moving average (SMA) was providing resistance at that time, but now the stock is fighting past that line in the sand. CRM has also managed to get back above its 200-day SMA in the process. Traders may want to use the April high of $165.30 as an entry trigger.
NYSE:CRMLong
by TradeStation
Bullish Ascending Triangle in MicrosoftMicrosoft has been squeezing into a range with breakout potential. Of all the big technology companies, it may emerge as the biggest beneficiary of coronavirus thanks to its cloud-computing, business software and videogaming. Last week’s earnings report beat across the board, but MSFT didn’t move much because it’s been trapped in a bullish ascending triangle. And now it may be trying to break out of that pattern. The triangle started taking shape in the first half of April. It became more clear after April 17, when MSFT hit resistance around $179. That’s near the close on February 21, immediately before the coronavirus correction began.
NASDAQ:MSFTLong
by TradeStation
Pfizer and BioNTech Dose First Participants in the U.S. Hey fellow Traders from TradingView, this is an update to the actual Situation and my previous Analysis If you agree with my Analysis or find it useful , please leave me a like for my work it would be greatly appreciated. Im still bullish and optimistic that BNTX participation will have a huge global impact. The stock seems to be news related, so expect it to make huge moves when they finally will announce to have completed those first worldwide clinical studies. The Moving Averages are lining up and signalizing us there will soon be a Price expansion. Assuming the 55 MA line serves as a support we cacn expect the stock to bounce off that and rise to the resistance battleground area. I´d place my Stop Loss below the next support pivot at either 36.85 to not risk gettiong shaken out before the upcoming outbreak. If you can handle that amount of risk. If not a LOD SL is always a great way to reduce risk. Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. This U.S. trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. "The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates, and is to be evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S. will enroll up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with a given dose level of a vaccine candidate once testing of that candidate and dose level in younger adults has provided initial evidence of safety and immunogenicity. Sites currently dosing participants include NYU Grossman School of Medicine and the University of Maryland School of Medicine. The University of Rochester Medical Center/Rochester Regional Health and Cincinnati Children’s Hospital Medical Center will begin enrollment shortly." Source by: NASDAQ:BNTX FWB:22UA investors.biontech.de Remember, this is only my opinion after considering all facts and informing myself about the Up/Downside of this stock. So no financial advise is given here. Always do your own reasearch. Thank you for taking the time and i hope to see you again in my next post! See you there Sincerly, Sebastian - TradingExperts Europe
NASDAQ:BNTXLong
by Sebastian-TradingExpertsEU
6
Activision - to reach new highsFor those that have been following my analysis on ATVI, you'll take note of how he price passed through the highlighted zone and bounced out in the upwards direction in the area I marked a couple of weeks back. With earnings coming in tomorrow, given the fact that COVID-19 has kept people home and the kickoff of the Call of Duty World Championship, I expect an earnings beat as well as a rally this week into the $70-$75 range before another rest period.
NASDAQ:ATVILong
by TradingGuru14
MSFT is likely to go down for some time .NASDAQ:MSFT is likely to go down to around 172 before bouncing up from there .If it doesn't , If it continues dropping below the 172 area and closes considerably below the 172 in an upcoming day (With a bearish candle) then price is likely to continue its drop until around the 167.5 mark .For people who bought MSFT earlier (Long term investment) I think it would be wise to hold it as long as it doesn't considerably close below the 164,5$ mark.
NASDAQ:MSFTShort
by StockAnalystPro
Advanced Micro Devices: The Bears Are Trying, But…Advanced Micro Devices was the top-performing member of the S&P 500 in both 2018 and 2019. Its last earnings report on April 28 was very middle-of-the-road. Results beat, and then management tried to talk down demand. Other chips like Intel and Qualcomm have struck a similarly cautious tone. However, investors know some positives lay in the future. They may see the bigger chip cycle (cloud, AI, 5G, mobile) resuming sooner rather than later, and not want to remain negative on a company that’s repeatedly shown leadership. This sentiment may be evident on the chart because AMD has refused to make new lows after earnings. The key level seems to be the April 21 close of $52.92. Remember that was a big negative session for the S&P 500, one day after oil went negative. Buyers defended AMD during that volatile day. The stock actually had more volume on April 21 than yesterday, following quarterly results. Let’s see if this price area continues to provide support. It also gives potential buyers a decent risk-management level in case the shares break to the downside.
NASDAQ:AMDLong
by TradeStation
2
Apple’s Range Is Tightening as Earnings ApproachApple's range is tightening with earnings due on Thursday afternoon. Is a breakout coming? The iPhone maker has stayed above its 8-day exponential moving average since the market jumped back to life on April 6. There were a few tests below it, but now that line is squeezing up to the top of the recent range around $288.25. It’s also near the 100-day simple moving average (SMA). A tight pattern like this, especially with waning volume, suggests traders may be waiting for quarterly results to jump in. Notice how the 5-day Average True Range (ATR) is back to its tightest reading since February 21, immediately before the coronavirus selloff began. AAPL is also holding above its 50-day SMA. The stock had a false breakdown under that line on April 21, but it quickly rebounded and has stayed above it since. From a fundamental perspective, Wall Street seems fully aware that coronavirus will hurt both supply and demand. IPhone production was delayed by factory outages. Big hits to income from the millions of lost jobs will also weigh on unit sales. But how long will those headwinds last? Investors seem to be looking out a little further in time and seeing Tim Cook’s initiatives paying off: Cheaper phones draw more users into AAPL’s growing services business. That’s a positive for valuations because recurring revenues tend to command higher multiples than hardware sales. AAPL has pursued that strategy lately by releasing the iPhone SE for $399. It also rolled out services like App Store and iCloud in 20 more countries across Africa, Europe and the Middle East. In conclusion, AAPL has made several major transformations over the years: First from Macs to iPods. Then, from iPods to iPhones. Now it’s evolving from iPhones to services. The result is a stickier business model with more operating leverage. Covid-19 or no Covid-19, the progress seems on track.
NASDAQ:AAPL
by TradeStation
Tesla Is Parked Above a Key Level. Will it Speed into Earnings?Tesla turned before the rest of the market, and quickly doubled from its low. Now the electric-car maker is parked above a key level, making traders wonder if it may accelerate higher. TSLA bottomed on March 18 , four sessions before the S&P 500 capitulated. It also passed above its 50-day simple moving average (SMA) on April 14 and has remained there, even with the broader market struggling at that line. It squeezed into a tight range as it consolidates and is now trying to break out of a small triangle. The stock will be in focus this week because earnings are due Wednesday afternoon. While few companies have been immune to the impact of coronavirus on global economies, TSLA has actually had some positive news before its results. On April 2 the company said first-quarter vehicle deliveries would crush estimates (88,400 vs 79,900 forecast). Then on April 15, LMC Automotive estimated that registrations in the key Chinese market rose more than 400 percent between February and March. Finally, some bigger perspective: TSLA’s market cap is $133 billion, but it still isn’t in the S&P 500 index. If it were, it would rank No. 41 between McDonald’s and Medtronic . The real story here could be that a major growth stock for the next several years may be sitting right in front of us, in the middle of its second major historic move. Earnings are nigh, short interest is high and a brief consolidation phase may be in the rearview mirror.
NASDAQ:TSLA
by TradeStation
2
Bullish Technical Setup provided by ALEC / Through 26NASDAQ:ALEC Hey Guys, today i´d like to showcase you a sharp ooking Long Setup for a shorter time frame. We are looking here at an uplifting and trending Bio TECH Stock that has shows previous Strenght when the market had its weakness. Alector, Inc. operates as a clinical-stage biopharmaceutical company. They are developing therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. No real profits are yet achieved for the Company but it still has a solid looking balance sheet. ALEC had a appropriate Consolidation Phase last week where it bounced back multiply times from the 26$ Resistance Level. Looking at the Hourly the Stock set ups very well it its given Range The Moving Averages dispaly that the Stock should be ready for a breakout expansion with a confirmation from high Volume following through. My Entry would be at 26.10 to not get trapped. Targets are 30, 32 and 36 I´d set my SL at LOD and then trail it with a 15min candel upwards to not give back any gains. This is only my opinion on technical Analysis and not a buy or sell recommendations. Do your own research before jumping into a bandwagon. Please leav me a like or a comment if you want to see more of my Analysis ! It would mean a lot to me and id´be greatly appreciated. Thanks, Sebastian - TradingExperts EU
NASDAQ:ALECLong
by Sebastian-TradingExpertsEU
Biontech AG Outbreak - First COVID-19 human vaccine trial test Hey fellow Trader, The uprising Biotechnology company from NASDAQ:BNTX Mainz, Germany is on its final steps from developing a vaccine for the actual Bio-weapon health crisis from the "new flu" . With Rolf Zinkernagel a brilliant Scientiests that can proudly say to win a nobelprice and a strong financial background , from big names in the Pharmaceutical field. When BioNTech AG announced to start with the first human vaccine tests after getting an approval in Europa , a US approval should follow shortly after also. We should expect News from those test in end May/june and if they´ve managed to create a proven vaccine afterwards im staying LONG in this Outbreak because its Trending and the Chances are high for a good R/R. A Golden Cross is forming and the Overall Stock is positive and with a low beta so less correlation risk in this given "Crazy Market" . So with a break of the 56 level we should see a strong move up. Goals are high and i think it could touch the 100 mark again with reactive move down to given support levels if they arent successful with their vaccine Therapy. STOPLOSS tight at 49,45 I hope this was helpful but it only displays my opionion and no financial adivce is given here. Sincerly, Sebastian
NASDAQ:BNTXLong
by Sebastian-TradingExpertsEU
1
Zynga, Unfazed by Market Crash, May be Coiling for a BreakoutAt times like this, with the vast majority of stocks below their 200-day simple moving averages (SMA), a name like Zynga stands out. The video-game developer has consolidated in a key price zone for the last 10 months. It gapped higher on a strong earnings report in early February and then slid along with the rest of the market as coronavirus spread. But it barely pulled back. ZNGA only closed below its 200-day SMA a handful of times before clawing higher. It made its low on March 17, almost a week before the broader S&P 500. The longer-term chart also seems to be forming a cup-and-handle pattern. ZNGA was already benefiting from stronger ad revenue before the coronavirus correction. Now it has the added catalyst of users spending more time on their mobile devices as they stay home. Analysts including Cowen and Bank of America have cited this trend in research notes. Oppenheimer also initiated the stock at “outperform” on March 18 with a $7.50 target price. Traders may want to watch ZNGA around its current levels. The stock had a weekly high of $6.85 on March 10, which was resistance again last Friday. A breakout of this zone, combined with potential steadying in the market, may draw buyers. Given how long it’s consolidated, now could be the time for an upside extension off the 200-day SMA.
ZLong
by TradeStation
2
Careful of Getting Sucked into Value Traps!One of the biggest questions after a correction like we just had is: What to buy on the rebound? Lots of stocks are trying to bounce, but which are more likely to perform the best? Longer-term charts can help answer the question. Let’s compare two very different corners of the market: The Nasdaq-100 (QQQ) and the Russell 2000 (IWM). QQQ barely hit a new 52-week low when the market crashed recently. Its trough of $164.93 matched prices from January 30, 2019. IWM , on the other hand, fell to its lowest level in more than four years – all the way down to $95.69. The higher low shows QQQ has more positive investor sentiment. IWM’s lower low shows just the opposite. Small caps (along with energy) were lagging before the coronavirus. They then fell much more when the market crashed. The moral of the story is that charts work. Never ignore underperformance or a lack of new highs. These simple technical indicators speak volumes about the underlying fundamentals. Speaking of fundamentals, did you know less than 20 percent of IWM’s portfolio is in the technology sector? It’s overweight industrials, which took a beating when coronavirus shut down the global economy. QQQ, on the other hand, is officially 44 percent technology. When you include “communication” companies like Alphabet and Facebook , it’s over 50 percent. Throw in Amazon.com (consumer discretionary) and it’s more like 59 percent. There are two takeaways. First, simple chart patterns like highs and lows tell us a lot about fundamentals. They’re also more fun to read than analyst reports. Second, just because something’s bouncing a lot doesn’t mean it will keep outperforming. In the case of IWM, the sharp rebound may be little more than a dead-cat bounce. It might seem counter-intuitive, but often the stocks that fall the least in a correction rise the most after. Disciplined trend followers stick with these patterns to avoid getting sucked into value traps.
NASDAQ:QQQLong
by TradeStation
MSFT, 25.3.2020Hi, traders. My name is Lukas and I am a beginner in trading, respectively, I only trade 6 months. But that means I have to do the necessary analyzes without it I can't trade. I want to show you how I work on myself and document my beginnings. I use Vix and my strategy is built on to return to average. I highlight the important support levels and resistances that flow from the volume profile, all drawn on graph. These zones determine the ability to respond in some way to the market from 1 to 3, with 1 being the largest. Short description of analysis: After yesterday's growth today I expect a slight consolidation, the market will gain energy with the help of the FED, and so will have room to rise until the next resistance. This happens after Microsoft teamed up with the WHO to introduce a hackathon about COVID-19. Of course, my analysis does not serve like market forecasts and I am not responsible for your trades if you use my analysis for your own trades. AND Chceck my new twitter :)
NASDAQ:MSFTLong
by Lucas_Sochulak
Tesla Has Pulled Back to Some Key LevelsTesla was one of the biggest movers in late 2019 and early 2020, more than tripling in value on a monster short squeeze. TradeStation highlighted the trend in early December and now it's back on our radar. TSLA has pulled back to an area where two levels are in play: First, it probed its 200-day moving average yesterday for the first time since October. ( Click here for the "Distance from MA" script featured on this chart.) Second, it tested old highs around $385 from 2017 and 2018. This may create the potential for classic trend following if current levels hold. There have also been some upgrades this week: Bank of America yesterday and Morgan Stanley today. Both raised it from the equivalent of "sell" to "hold," mostly based on the depth of its recent pullback. In conclusion, there's still plenty of volatility and uncertainty out there. But TSLA was one of the strongest names before coronavirus hammered the market. Investors hoping to put money to work may want to see if these levels hold in coming sessions.
NASDAQ:TSLA
by TradeStation
3
GOOGL, CAN BE ANY TRADE DONE IN THIS CRAZY TIMES? 10.3.2020Hi, traders. My name is Lukas and I am a beginner in trading, respectively, I only trade 6 months. But that means I have to do the necessary analyzes without it I can't trade. I want to show you how I work on myself and document my beginnings. I use Vix and my strategy is built on to return to average. I highlight the important support levels and resistances that flow from the volume profile, all drawn on graph. These zones determine the ability to respond in some way to the market from 1 to 3, with 1 being the largest. Short description of analysis: As you can see, our zones work beautifully despite being in a time of fear and pessimism. In the short term, any speculation is very risky. Focus on longer periods of 6 months or more. If you want to risk and trade in this highly volatile period, then we can get to 1000 USD in the event of further rinsing. But remember every short position is very risky. Of course, my analysis does not serve like market forecasts and I am not responsible for your trades if you use my analysis for your own trades.
NASDAQ:GOOGLLong
by Lucas_Sochulak
Is Alibaba Immune to Coronavirus? RS Suggests It May BeRelative Strength shows when a stock is outperforming peers. It can be very useful when the market corrects, like we saw last week. Crisis often turns into opportunity once the dust settles. One of the biggest surprises from RS recently is the strength in Chinese names. Despite coronavirus originating on the Mainland, many of the country's big liquid stocks have corrected less than the broader market. Alibaba is a case in point. When the S&P 500 and Nasdaq-100 were crashing down toward their 200-day simple moving averages (SMA) last week, BABA didn't even come close to dropping that much. That's a classic sign of relative strength. The e-commerce giant broke out of a long basing pattern in late 2019 and quickly surged to new highs. It then consolidated in price, and now is completing an ABC flat pattern, or double bottom. Its swings have also been much tamer than the rest of the market. Another positive last Friday was the slight undercut of January's support around $199.50. When a stock undercuts support it often takes out obvious stops and shakes out the weak hands. The result is a false breakdown. Traders looking for an entry in BABA may want to look for a breakout above the 21-day and 50-day SMAs, which are slightly above the current price range.
NYSE:BABALong
by TradeStation
2
Uber Is About to Have a Golden CrossRide-sharing company Uber Technologies has had bad times and good times since its IPO last May. First, it had to cut its offer price. Then it fell all the way down to the mid-20s as investors worried about its profitability and sprawling operations. But one by one, CEO Dara Khosrowshahi has moved to address those issues. He's exited non-core businesses and focused on making money. As a result, UBER was able to move forward its profitability goal the last time it reported earnings on February 6. The stock gapped higher at the time, but then coronavirus came along and smashed it down to where it began 2020. Meanwhile, enough time has passed for UBER's 200-day simple moving average (SMA) to appear. And guess what? Its 50-day SMA is about to rise up through the 200-day SMA. A "Golden Cross," could potentially occur in the next 1-2 sessions. Another pattern on the chart is a tight ascending triangle since last Thursday. UBER's made incrementally higher lows while pushing against resistance at $34. That could be a potential trigger level for traders looking to hail a ride on the stock.
NYSE:UBERLong
by TradeStation